DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Mobi Health News - ECG

SEPTEMBER 17, 2024

About a million possible cases of atrial fibrillation, a known risk for stroke, go undetected in Japan. The AI lineup currently covers both continuous ECG tracking and AFib detection. You are currently developing a new AI to detect AFib. A local startup is introducing an innovative AI targeting this growing danger.

AFIB 41

AFIB Stroke Strokes Technology 41

Cardiomatics

APRIL 5, 2024

Prolonged ambulatory ECG monitoring, commonly referred to as Holter testing, increases the chance of detecting abnormalities responsible for the symptoms of cardiovascular diseases, especially those whose pathognomonic symptoms occur only periodically. AFIB/AFL – atrial fibrillation or atrial flutter episodes.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Electrocardiogram 92

DAIC

DECEMBER 19, 2023

OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

FEBRUARY 7, 2024

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. Cardiovascular disease is the leading cause of death globally, taking an estimated 695,000 lives in 2021 in the United States, about 1 in every 5 deaths, according to the CDC.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

FEBRUARY 2, 2024

Cardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. [1] Cardiovascular disease is the leading cause of death globally - affecting millions of individuals and placing a significant burden on healthcare systems today. [1]

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101